Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06548022 · ClinicalTrials.gov registry record · NA

Rare Group Problem Management Plus

A NA study of Anxiety and Post Traumatic Stress Disorder, sponsored by Children's National Research Institute.

Active
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT06548022: Active NA study of Anxiety and Post Traumatic Stress Disorder, sponsored by Children's National Research Institute.

NCT06548022 is a NA study of Anxiety and Post Traumatic Stress Disorder that is active but no longer recruiting, run by Children's National Research Institute. The registered enrollment target is 8 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06548022, a NA study of Anxiety and Post Traumatic Stress Disorder, is active but no longer recruiting, sponsored by Children's National Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

Participants are being asked to be in the study if they are the parent or legal guardian of a child (\>1 year or \<18 years old) with a rare condition. The group based psychoeducational intervention is called Rare Group Problem Management Plus. Rare Group PM Plus may help adults with practical and emotional problems. It is a group program (there will be other men or women with similar problems) It happens once a week for 5 weeks (each session lasts 90 minutes) Participants will complete assessments before they start Rare Group PM+. Participants will also complete the same assessments within a few weeks of completing Rare Group PM+. Assessments should only take one hour. Study visits are by Telemedicine. Participants will need a smart phone or tablet. If they do not have a smart phone or tablet, the study team will help with this. Participants will not receive any materials or money or medication.

Primary Outcome

As measured by retention at 2 weeks post-intervention assessment

Conditions Studied

Anxiety Post Traumatic Stress Disorder Depressive Symptoms Problems Psychosocial

Interventions

  • BEHAVIORAL Rare Group Problem Management Plus

Study Locations (1)

District of Columbia

  • Children's National Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2024-02-05
Est. Completion 2025-11-30
Phase NA
Children's National Research Institute

92 total trials

What the registry record for NCT06548022 still lists

NCT06548022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (98% lower).

The record links to 4 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Rare Group Problem Management Plus is the first listed.

NCT06548022 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT06548022 about?

NCT06548022 is a clinical study titled "Rare Group Problem Management Plus". Participants are being asked to be in the study if they are the parent or legal guardian of a child (\>1 year or \<18 years old) with a rare condition. The group based psychoeducational intervention is called Rare Group Problem Management Plus. Rare Group PM Plus may help adults with practical and...

What is the current status of trial NCT06548022?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2024-02-05. Estimated completion is 2025-11-30.

What conditions does trial NCT06548022 study?

This clinical trial studies the following conditions: Anxiety, Post Traumatic Stress Disorder, Depressive Symptoms, Problems Psychosocial.

What interventions are being tested in trial NCT06548022?

The interventions under investigation include: Rare Group Problem Management Plus (BEHAVIORAL).

Who is sponsoring clinical trial NCT06548022?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06548022 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06548022's enrollment target sits among peer trials

8 361st of 364 higher than 4 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06548022, the US trial registry maintained by the National Library of Medicine. NCT06548022 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.